Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Catherine Sattler"'
Autor:
Jaren W. Landen, Niels Andreasen, Carol Cronenberger, Henrik Östlund, Martin M. Bednar, Anne Börjesson-Hanson, Pamela F. Schwartz, Catherine Sattler, Brendon Binneman
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction The safety, pharmacokinetics, and effect on peripheral and central amyloid β (Aβ) of multiple doses of ponezumab, an anti-Aβ monoclonal antibody, were characterized in subjects with mild-to-moderate Alzheimer's disease treated for 1 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b05e9a2f46f21ad971447eaf9632b73e
http://europepmc.org/articles/PMC5651442
http://europepmc.org/articles/PMC5651442
Autor:
Sharon Cohen, Qinying Zhao, Carol Cronenberger, Aaron H. Burstein, Pamela F. Schwartz, William T. Duggan, Martin M. Bednar, Kejal Kantarci, Clifford R. Jack, Brendon Binneman, Scot Styren, Jae-Hong Lee, Jaren W. Landen, Clare B. Billing, Ken J. Sprenger, Catherine Sattler
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction Multiple intravenous doses of ponezumab, an anti-amyloid antibody, were evaluated in subjects with mild-to-moderate Alzheimer's disease (AD). Methods In part A, 77 subjects were randomized to ponezumab 0.1, 0.5, or 1 mg/kg (75 treated) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5783ab75f707d14e03dc8c2932164ab
https://doi.org/10.1016/j.trci.2017.04.003
https://doi.org/10.1016/j.trci.2017.04.003
Autor:
Almasa, Bass, Anna, Plotka, Khurshid, Mridha, Catherine, Sattler, Albert M, Kim, David R, Plowchalk
Publikováno v:
Health Science Reports
Aim Prior to the discontinuation of bococizumab's clinical development, it was considered advantageous to develop an infrequent dosing regimen (eg, monthly). Therefore, we conducted a phase 1 study to evaluate the pharmacokinetics, pharmacodynamics,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05320977192c803d72c2d3046c333112
https://pubmed.ncbi.nlm.nih.gov/30623096
https://pubmed.ncbi.nlm.nih.gov/30623096
Publikováno v:
Cardiovascular Therapeutics. 35:e12278
SummaryAim To characterize the single-dose pharmacokinetics (PK) and pharmacodynamics (PD) of bococizumab, a monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9), administered subcutaneously (s.c.) to the abdomen, thig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d6b33ea3106e17c3fda875a31f005e5
https://doi.org/10.1111/1755-5922.12278
https://doi.org/10.1111/1755-5922.12278
Autor:
Catherine Sattler, Aaron H. Burstein, Scot Styren, Clare B. Billing, Carol Cronenberger, Martin M. Bednar, Sharon Cohen, Jae-Hong Lee, Jaren W. Landen, Clifford R. Jack
Publikováno v:
Alzheimer's & Dementia. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7654fea08805231824de8be9b29229b3
https://doi.org/10.1016/j.jalz.2012.05.1913
https://doi.org/10.1016/j.jalz.2012.05.1913
Autor:
Brendon Binneman, Pam Schwartz, Niels Andreasen, Carol Cronenberger, Catherine Sattler, Martin M. Bednar, James Kupiec, Henrik Östlund, Anne Börjesson-Hanson, Jaren W. Landen
Publikováno v:
Alzheimer's & Dementia. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4055adfde606b3aca4e8d8616b6e2c2
https://doi.org/10.1016/j.jalz.2012.05.1914
https://doi.org/10.1016/j.jalz.2012.05.1914
Autor:
JClifford R. Jack, Denise A. Reyes, Jaren W. Landen, Catherine Sattler, Matt A. Bernstein, James T. Kupiec, Kajal Kantarci, Martin M. Bednar, Brett J. Borowski, Aaron H. Burstein
Publikováno v:
Alzheimer's & Dementia. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::466147c174de09048cecb4b7c1263b48
https://doi.org/10.1016/j.jalz.2010.05.1424
https://doi.org/10.1016/j.jalz.2010.05.1424